GSK-BEL115467

Study Sponsor: GSK

Study Title

A Randomized, Double-Blind, Placebo-Controlled 52-Week Study to Assess Adverse Events of Special Interest in Adults with Active, Autoantibody-Positive Systemic Lupus Erythematosus Receiving Belimumab

Medicine or Vaccine (generic name)

belimumab

Sponsor Identification Number

BEL115467

Trial Registry Identification Number(#'s)

NCT01705977 2011-005667-25

Medical Condition

Systemic Lupus Erythematosus

Phase

Phase 4

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=115467

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT01705977

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2011-005667-25

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This study is available in CDISC format.

Date Added to this Site

January 2021